These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 25086666)

  • 21. Increased burden of deleterious variants in essential genes in autism spectrum disorder.
    Ji X; Kember RL; Brown CD; Bućan M
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15054-15059. PubMed ID: 27956632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.
    Berkel S; Marshall CR; Weiss B; Howe J; Roeth R; Moog U; Endris V; Roberts W; Szatmari P; Pinto D; Bonin M; Riess A; Engels H; Sprengel R; Scherer SW; Rappold GA
    Nat Genet; 2010 Jun; 42(6):489-91. PubMed ID: 20473310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder.
    Uddin M; Tammimies K; Pellecchia G; Alipanahi B; Hu P; Wang Z; Pinto D; Lau L; Nalpathamkalam T; Marshall CR; Blencowe BJ; Frey BJ; Merico D; Yuen RK; Scherer SW
    Nat Genet; 2014 Jul; 46(7):742-7. PubMed ID: 24859339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia.
    Takata A; Ionita-Laza I; Gogos JA; Xu B; Karayiorgou M
    Neuron; 2016 Mar; 89(5):940-7. PubMed ID: 26938441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder.
    Takata A; Miyake N; Tsurusaki Y; Fukai R; Miyatake S; Koshimizu E; Kushima I; Okada T; Morikawa M; Uno Y; Ishizuka K; Nakamura K; Tsujii M; Yoshikawa T; Toyota T; Okamoto N; Hiraki Y; Hashimoto R; Yasuda Y; Saitoh S; Ohashi K; Sakai Y; Ohga S; Hara T; Kato M; Nakamura K; Ito A; Seiwa C; Shirahata E; Osaka H; Matsumoto A; Takeshita S; Tohyama J; Saikusa T; Matsuishi T; Nakamura T; Tsuboi T; Kato T; Suzuki T; Saitsu H; Nakashima M; Mizuguchi T; Tanaka F; Mori N; Ozaki N; Matsumoto N
    Cell Rep; 2018 Jan; 22(3):734-747. PubMed ID: 29346770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders.
    Schaaf CP; Sabo A; Sakai Y; Crosby J; Muzny D; Hawes A; Lewis L; Akbar H; Varghese R; Boerwinkle E; Gibbs RA; Zoghbi HY
    Hum Mol Genet; 2011 Sep; 20(17):3366-75. PubMed ID: 21624971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.
    O'Roak BJ; Vives L; Fu W; Egertson JD; Stanaway IB; Phelps IG; Carvill G; Kumar A; Lee C; Ankenman K; Munson J; Hiatt JB; Turner EH; Levy R; O'Day DR; Krumm N; Coe BP; Martin BK; Borenstein E; Nickerson DA; Mefford HC; Doherty D; Akey JM; Bernier R; Eichler EE; Shendure J
    Science; 2012 Dec; 338(6114):1619-22. PubMed ID: 23160955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.
    Leblond CS; Nava C; Polge A; Gauthier J; Huguet G; Lumbroso S; Giuliano F; Stordeur C; Depienne C; Mouzat K; Pinto D; Howe J; Lemière N; Durand CM; Guibert J; Ey E; Toro R; Peyre H; Mathieu A; Amsellem F; Rastam M; Gillberg IC; Rappold GA; Holt R; Monaco AP; Maestrini E; Galan P; Heron D; Jacquette A; Afenjar A; Rastetter A; Brice A; Devillard F; Assouline B; Laffargue F; Lespinasse J; Chiesa J; Rivier F; Bonneau D; Regnault B; Zelenika D; Delepine M; Lathrop M; Sanlaville D; Schluth-Bolard C; Edery P; Perrin L; Tabet AC; Schmeisser MJ; Boeckers TM; Coleman M; Sato D; Szatmari P; Scherer SW; Rouleau GA; Betancur C; Leboyer M; Gillberg C; Delorme R; Bourgeron T
    PLoS Genet; 2014 Sep; 10(9):e1004580. PubMed ID: 25188300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic landscapes of autism spectrum disorders.
    Huguet G; Ey E; Bourgeron T
    Annu Rev Genomics Hum Genet; 2013; 14():191-213. PubMed ID: 23875794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo mutations within metabolism networks of amino acid/protein/energy in Chinese autistic children with intellectual disability.
    Chen WX; Liu B; Zhou L; Xiong X; Fu J; Huang ZF; Tan T; Tang M; Wang J; Tang YP
    Hum Genomics; 2022 Nov; 16(1):52. PubMed ID: 36320054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic, environmental, and epigenetic contribution to the susceptibility to autism spectrum disorders].
    Díaz-Anzaldúa A; Díaz-Martínez A
    Rev Neurol; 2013 Dec; 57(12):556-68. PubMed ID: 24288105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility.
    Bi C; Wu J; Jiang T; Liu Q; Cai W; Yu P; Cai T; Zhao M; Jiang YH; Sun ZS
    Hum Mutat; 2012 Dec; 33(12):1635-8. PubMed ID: 22865819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Statistical Framework for Mapping Risk Genes from De Novo Mutations in Whole-Genome-Sequencing Studies.
    Liu Y; Liang Y; Cicek AE; Li Z; Li J; Muhle RA; Krenzer M; Mei Y; Wang Y; Knoblauch N; Morrison J; Zhao S; Jiang Y; Geller E; Ionita-Laza I; Wu J; Xia K; Noonan JP; Sun ZS; He X
    Am J Hum Genet; 2018 Jun; 102(6):1031-1047. PubMed ID: 29754769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.
    Betancur C
    Brain Res; 2011 Mar; 1380():42-77. PubMed ID: 21129364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in HECW2 are associated with intellectual disability and epilepsy.
    Halvardson J; Zhao JJ; Zaghlool A; Wentzel C; Georgii-Hemming P; Månsson E; Ederth Sävmarker H; Brandberg G; Soussi Zander C; Thuresson AC; Feuk L
    J Med Genet; 2016 Oct; 53(10):697-704. PubMed ID: 27334371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder.
    Dong S; Walker MF; Carriero NJ; DiCola M; Willsey AJ; Ye AY; Waqar Z; Gonzalez LE; Overton JD; Frahm S; Keaney JF; Teran NA; Dea J; Mandell JD; Hus Bal V; Sullivan CA; DiLullo NM; Khalil RO; Gockley J; Yuksel Z; Sertel SM; Ercan-Sencicek AG; Gupta AR; Mane SM; Sheldon M; Brooks AI; Roeder K; Devlin B; State MW; Wei L; Sanders SJ
    Cell Rep; 2014 Oct; 9(1):16-23. PubMed ID: 25284784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of autism-related
    Wen Z; Cheng TL; Li GZ; Sun SB; Yu SY; Zhang Y; Du YS; Qiu Z
    Mol Autism; 2017; 8():43. PubMed ID: 28785396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-genome sequencing of quartet families with autism spectrum disorder.
    Yuen RK; Thiruvahindrapuram B; Merico D; Walker S; Tammimies K; Hoang N; Chrysler C; Nalpathamkalam T; Pellecchia G; Liu Y; Gazzellone MJ; D'Abate L; Deneault E; Howe JL; Liu RS; Thompson A; Zarrei M; Uddin M; Marshall CR; Ring RH; Zwaigenbaum L; Ray PN; Weksberg R; Carter MT; Fernandez BA; Roberts W; Szatmari P; Scherer SW
    Nat Med; 2015 Feb; 21(2):185-91. PubMed ID: 25621899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The implications of de novo coding mutations in simplex autism families.
    Utami KH
    Clin Genet; 2015 May; 87(5):428-9. PubMed ID: 25753786
    [No Abstract]   [Full Text] [Related]  

  • 40. A strategy to identify de novo mutations in common disorders such as autism and schizophrenia.
    Julie G; Hamdan FF; Rouleau GA
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21712793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.